<p>SG Americas Securities LLC 在第三季度購買了 Astrana Health, Inc. (NASDAQ:ASTH - 免費報告) 的新頭寸，根據其最近向證券交易委員會的披露。這家機構投資者購買了 37,460 股該公司的股票，價值約為 1,062,000 美元。SG Americas Securities LLC 在最近的報告期末持有 Astrana Health 約 0.07% 的股份。</p>
<p>獲取 <strong>Astrana Health</strong> 警報：</p>
<p>其他幾家機構投資者也對 ASTH 的頭寸進行了調整。加拿大皇家銀行在第一季度將其在 Astrana Health 的持股增加了 6.5%。加拿大皇家銀行目前擁有 278,619 股該公司的股票，價值 8,640,000 美元，此前在上個季度又購買了 17,028 股。AQR Capital Management LLC 在第一季度獲得了 Astrana Health 的新頭寸，價值 933,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度將其在 Astrana Health 的持股增加了 5.2%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前擁有 25,768 股該公司的股票，價值 799,000 美元，此前在上個季度又購買了 1,263 股。Jones Financial Companies Lllp 在第一季度將其在 Astrana Health 的持股增加了 4,365.2%。Jones Financial Companies Lllp 目前擁有 11,163 股該公司的股票，價值 346,000 美元，此前在上個季度又購買了 10,913 股。最後，Intech Investment Management LLC 在第一季度將其在 Astrana Health 的持股增加了 5.8%。Intech Investment Management LLC 目前擁有 44,586 股該公司的股票，價值 1,383,000 美元，此前在上個季度又購買了 2,462 股。當前 52.77% 的股票由機構投資者和對沖基金持有。</p>
<h2>Astrana Health 股票下跌 1.6%</h2>
<p>ASTH 週一開盤價為 26.95 美元。該公司的 50 日移動平均線為 24.00 美元，200 日移動平均線為 26.88 美元。該股票的市值為 15.2 億美元，市盈率為 141.85，市盈率/增長比率為 0.67，貝塔值為 0.87。該公司的流動比率為 1.40，速動比率為 1.40，債務與股本比率為 1.27。Astrana Health, Inc. 的一年低點為 20.12 美元，一年高點為 39.97 美元。</p>
<p>Astrana Health (NASDAQ:ASTH - 獲取免費報告) 最近於 11 月 6 日發佈了其財報。該公司報告本季度每股收益為 0.01 美元，低於市場共識預期的 0.47 美元，差距為 0.46 美元。Astrana Health 的淨利潤率為 0.33%，股本回報率為 1.26%。該公司本季度的收入為 9.5605 億美元，而分析師預期為 9.5283 億美元。在去年同期，該公司每股收益為 0.33 美元。與去年同期相比，Astrana Health 本季度的收入增長了 99.7%。整體來看，賣方分析師預計 Astrana Health, Inc. 本年度將發佈 1.15 美元的每股收益。</p>
<h2>華爾街分析師預測增長</h2>
<p>幾家研究公司對 ASTH 發表了看法。Needham &amp; Company LLC 於 12 月 12 日星期五開始對 Astrana Health 進行覆蓋。他們對該股票設定了 “買入” 評級和 28.00 美元的目標價。Jefferies Financial Group 在 11 月 25 日星期二的研究報告中重申了對 Astrana Health 股票的 “買入” 評級。Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Astrana Health 股票的 “賣出（d+）” 評級。TD Cowen 將 Astrana Health 的目標價從 40.00 美元下調至 35.00 美元，並在 11 月 10 日星期一的報告中對該股票設定了 “買入” 評級。最後，BTIG Research 在 11 月 7 日星期五的研究報告中將 Astrana Health 股票的目標價從 50.00 美元下調至 45.00 美元，並對該公司設定了 “買入” 評級。八位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，Astrana Health 目前的共識評級為 “適度買入”，共識目標價為 41.33 美元。</p>
<p><strong>查看我們對 ASTH 的最新股票分析</strong></p>
<h2>關於 Astrana Health</h2>
<p>（免費報告）</p>
<p>Astrana Health, Inc. 是一家以醫生為中心的技術驅動醫療管理公司，在美國提供醫療服務。它通過三個部門運營：護理合作伙伴、護理交付和護理賦能。該公司利用其專有的人口健康管理和醫療服務平台，運營一個綜合的、基於價值的醫療模型，使其網絡中的提供者能夠為患者提供護理。它為患者、家庭、初級保健醫生、專家、急性護理醫院、替代住院護理場所、醫生集團和健康計劃提供護理協調服務。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比 Astrana Health 更好</li>
<li>Elon 將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 悄然激活</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
<li>新法律：國會批准數字美元的設立？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVNUSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVNUSA"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Astrana Health 嗎？</h2>
<p>在您考慮 Astrana Health 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向客户推薦現在購買，以便在更廣泛的市場注意到之前……而 Astrana Health 並不在名單上。</p>
<p>雖然 Astrana Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ASTH

<p>SG Americas Securities LLC 已收購 Astrana Health, Inc.（納斯達克代碼：ASTH）37,460 股，價值約為 1,062,000 美元，代表約 0.07% 的持股比例。其他機構投資者也對 ASTH 的持倉進行了調整。該股票目前下跌 1.6%，交易價格為 26.95 美元，市值為 15.2 億美元。Astrana Health 報告的年收入增長為 99.7%，但未能達到每股收益（EPS）預期。分析師對該股票的評級不一，普遍評級為 “適度買入”，目標價格為 41.33 美元</p>

<p>SG Americas Securities LLC bought a new position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 37,460 shares of the company's stock, valued at approximately $1,062,000. SG Americas Securities LLC owned about 0.07% of Astrana Health at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>SG Americas Securities LLC 在第三季度購買了 Astrana Health, Inc. (NASDAQ:ASTH - 免費報告) 的新頭寸，根據其最近向證券交易委員會的披露。這家機構投資者購買了 37,460 股該公司的股票，價值約為 1,062,000 美元。SG Americas Securities LLC 在最近的報告期末持有 Astrana Health 約 0.07% 的股份。</p>
</div><p>Get <strong>Astrana Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Astrana Health</strong> 警報：</p>
</div><p>Several other institutional investors have also made changes to their positions in ASTH. Royal Bank of Canada increased its holdings in Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company's stock worth $8,640,000 after buying an additional 17,028 shares during the last quarter. AQR Capital Management LLC acquired a new position in shares of Astrana Health during the 1st quarter worth $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock valued at $799,000 after purchasing an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Astrana Health by 4,365.2% during the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company's stock valued at $346,000 after purchasing an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC lifted its stake in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company's stock valued at $1,383,000 after purchasing an additional 2,462 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家機構投資者也對 ASTH 的頭寸進行了調整。加拿大皇家銀行在第一季度將其在 Astrana Health 的持股增加了 6.5%。加拿大皇家銀行目前擁有 278,619 股該公司的股票，價值 8,640,000 美元，此前在上個季度又購買了 17,028 股。AQR Capital Management LLC 在第一季度獲得了 Astrana Health 的新頭寸，價值 933,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度將其在 Astrana Health 的持股增加了 5.2%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前擁有 25,768 股該公司的股票，價值 799,000 美元，此前在上個季度又購買了 1,263 股。Jones Financial Companies Lllp 在第一季度將其在 Astrana Health 的持股增加了 4,365.2%。Jones Financial Companies Lllp 目前擁有 11,163 股該公司的股票，價值 346,000 美元，此前在上個季度又購買了 10,913 股。最後，Intech Investment Management LLC 在第一季度將其在 Astrana Health 的持股增加了 5.8%。Intech Investment Management LLC 目前擁有 44,586 股該公司的股票，價值 1,383,000 美元，此前在上個季度又購買了 2,462 股。當前 52.77% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Astrana Health Stock Down 1.6%</h2>
<div class="lb-trans"><h2>Astrana Health 股票下跌 1.6%</h2>
</div><p>ASTH opened at $26.95 on Monday. The business has a 50 day moving average of $24.00 and a 200-day moving average of $26.88. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 141.85, a P/E/G ratio of 0.67 and a beta of 0.87. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. Astrana Health, Inc. has a 1-year low of $20.12 and a 1-year high of $39.97.</p>
<div class="lb-trans"><p>ASTH 週一開盤價為 26.95 美元。該公司的 50 日移動平均線為 24.00 美元，200 日移動平均線為 26.88 美元。該股票的市值為 15.2 億美元，市盈率為 141.85，市盈率/增長比率為 0.67，貝塔值為 0.87。該公司的流動比率為 1.40，速動比率為 1.40，債務與股本比率為 1.27。Astrana Health, Inc. 的一年低點為 20.12 美元，一年高點為 39.97 美元。</p>
</div><p>Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.46). Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The company had revenue of $956.05 million for the quarter, compared to analyst estimates of $952.83 million. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astrana Health's revenue for the quarter was up 99.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.</p>
<div class="lb-trans"><p>Astrana Health (NASDAQ:ASTH - 獲取免費報告) 最近於 11 月 6 日發佈了其財報。該公司報告本季度每股收益為 0.01 美元，低於市場共識預期的 0.47 美元，差距為 0.46 美元。Astrana Health 的淨利潤率為 0.33%，股本回報率為 1.26%。該公司本季度的收入為 9.5605 億美元，而分析師預期為 9.5283 億美元。在去年同期，該公司每股收益為 0.33 美元。與去年同期相比，Astrana Health 本季度的收入增長了 99.7%。整體來看，賣方分析師預計 Astrana Health, Inc. 本年度將發佈 1.15 美元的每股收益。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several research firms have weighed in on ASTH. Needham &amp; Company LLC began coverage on Astrana Health in a report on Friday, December 12th. They set a &#34;buy&#34; rating and a $28.00 target price on the stock. Jefferies Financial Group reissued a &#34;buy&#34; rating on shares of Astrana Health in a research note on Tuesday, November 25th. Weiss Ratings reaffirmed a &#34;sell (d+)&#34; rating on shares of Astrana Health in a research report on Monday, December 29th. TD Cowen lowered their price target on Astrana Health from $40.00 to $35.00 and set a &#34;buy&#34; rating on the stock in a report on Monday, November 10th. Finally, BTIG Research reduced their price objective on shares of Astrana Health from $50.00 to $45.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Astrana Health presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $41.33.</p>
<div class="lb-trans"><p>幾家研究公司對 ASTH 發表了看法。Needham &amp; Company LLC 於 12 月 12 日星期五開始對 Astrana Health 進行覆蓋。他們對該股票設定了 “買入” 評級和 28.00 美元的目標價。Jefferies Financial Group 在 11 月 25 日星期二的研究報告中重申了對 Astrana Health 股票的 “買入” 評級。Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Astrana Health 股票的 “賣出（d+）” 評級。TD Cowen 將 Astrana Health 的目標價從 40.00 美元下調至 35.00 美元，並在 11 月 10 日星期一的報告中對該股票設定了 “買入” 評級。最後，BTIG Research 在 11 月 7 日星期五的研究報告中將 Astrana Health 股票的目標價從 50.00 美元下調至 45.00 美元，並對該公司設定了 “買入” 評級。八位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，Astrana Health 目前的共識評級為 “適度買入”，共識目標價為 41.33 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on ASTH</strong></p>
<div class="lb-trans"><p><strong>查看我們對 ASTH 的最新股票分析</strong></p>
</div><h2>About Astrana Health</h2>
<div class="lb-trans"><h2>關於 Astrana Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.</p>
<div class="lb-trans"><p>Astrana Health, Inc. 是一家以醫生為中心的技術驅動醫療管理公司，在美國提供醫療服務。它通過三個部門運營：護理合作伙伴、護理交付和護理賦能。該公司利用其專有的人口健康管理和醫療服務平台，運營一個綜合的、基於價值的醫療模型，使其網絡中的提供者能夠為患者提供護理。它為患者、家庭、初級保健醫生、專家、急性護理醫院、替代住院護理場所、醫生集團和健康計劃提供護理協調服務。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Astrana Health</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Astrana Health 更好</li>
<li>Elon 將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 悄然激活</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
<li>新法律：國會批准數字美元的設立？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVNUSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ASTH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Astrana Health Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Astrana Health 嗎？</h2>
</div><p>Before you consider Astrana Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Astrana Health 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向客户推薦現在購買，以便在更廣泛的市場注意到之前……而 Astrana Health 並不在名單上。</p>
</div><p>While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Astrana Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

SG Americas Securities LLC 收購了 Astrana Health, Inc. $ASTH 的新股